Natural immunity enhancing and cholesterol
lowering supplement.
Maximum stimulation of the macrophage with Beta 1,3,1/6 Glucan
The body's ultimate self-defense mechanism
Starting in the 1940's, researchers have investigated the nutritional
benefits of Beta Glucan. Derived from broken cell walls of yeast, mushrooms,
barley and oats, Beta Glucans are capable of reducing unhealthy amounts of serum
cholesterol and boosting the immune system.
Beta Glucan is a powerful immune stimulator, activating the macrophage in the
immune system. Studies have found this product not only has a positive action on
the macrophage, but on B lymphocytes, natural killer cells and suppressor T
cells. In addition to these important functions, Beta Glucan is an effective
antioxidant and free radical scavenger. Beta Glucan is a safe, non-toxic, and
orally effective supplement for those who wish to enhance their immune system
and lower cholesterol levels. Beta Glucan is the only glucan found effective
in preventing coronary heart disease by SIGNIFICANTLY lowering LDL blood
cholesterol and increasing HDL (good) cholesterol levels. Read the U.S. Food and
Drug Administration's official announcement at FDA APPROVES BETA GLUCAN FOR
PREVENTING CORONARY HEART DISEASE
Quaker Oats, the cereal manufacturer, has a wonderful website clearly
explaining how the abundant beta glucan in oatmeal provides remarkable
cholesterol lowering power. Please remember you would have to eat 32 bowls of
Quaker Oats to get the same amount of beta glucan you get in one of our 200 mg
tablets. Just click your back button to return to this site. How Oats Work
Quantity: 60 capsules
Daily Use: 1 tablets daily. Each tablet has 200mg of Beta 1,3,1/6
Glucan
Pill Size: Small capsules
Shelf Life: 2 years
Fillers: None, pure Beta Glucan
Initial Source: Yeast cell wall-Beta Glucan.
Processing: Raw material undergoes proprietary process to extract
from cell wall. Material is dry blended, carefully micronized and
encapsulated.
Contains No: Dairy, corn, soy, wheat, sugar, starch, salt,
preservatives or color.
Contraindications: If you are pregnant, nursing or using
prescription drugs, consult your physician before use.
Drug Interactions: None known
Ingredient Table: One capsule provides:Beta 1,3 Glucan 200 mg
There have been over 1,000 research papers on Beta 1,3-D
Glucan since the 1960's. Research backed by prestigious institutions such as the
U.S. Food and Drug Administration (see above report), Harvard, Tulane, Baylor,
McGill, University of California, Duke, Washington, Armed Forces Radiology
Research Institute, and other institutions all demonstrate the high immune
activating properties of Beta Glucan. Beta Glucan has been found to stimulate or
modulate macrophage cells (leukocytes, or white blood cells).
.Macrophage
cells (big eater) play an essential and pivotal role in the initiation and
maintenance of the immune system and how it works.
Macrophages are the cells that recognize, engulf and destroy any cells,
organisms and substances that are not natural or required by the body (bacteria;
viruses; fungi; dead, mutated or tumor cells; etc.). It also can produce a
number of essential cytokines that are able to stimulate the immune system in
general and boost bone marrow production. In addition to having a huge appetite
for toxins, macrophages play an essential role in the initiation and maintenance
of the immune response. Once a foreign body attacks the body, the macrophages
become activated, a chain reaction occurs that mobilizes and amplifies the
entire immune system and how it works.
Keep Your Immune System Strong
Our immune system holds the key toour body's health. It protects our bodies
against viruses, bacteria, fungi, parasites, etc. It is a miraculous complex
network of organs that contain cells that recognize & destroy foreign
invaders. Some individuals, because of age, chronic infection, poor nutrition,
stress, unhealthy lifestyle, or environmental toxins have a compromised immune
system. They are susceptible to all of the following problems: arthritis:
reduced wound healing capacity; reduced bone marrow proliferation with resulting
lowered white cell counts and anemia; increased incidence of cancers; and
increased incidence of viral, fungal, and bacterial infection.
Note: Many manufacturers of Beta Glucan sell an inferior product for
highly inflated prices. For example, local health food stores in US and
Canada often sell NSC's Beta Glucan, where 30 tablets often retail in excess of
$70! Each tablet only contains 10mg of Beta Glucan, only 5% the potency of a
single tablet of Our product! With our product you receive an
exceptional value: 60, 200mg capsules per bottle, and our sales price is just
$22.95. You receive over 200 times the value of NSC and many other brands of
Beta Glucan.
T97-5
Judith Foulke (202) 205-4144 January 21, 1997 Broadcast Media (301) 827-3434
Consumer Hotline (800) 532-4440
FDA ALLOWS WHOLE OAT FOODS TO MAKE HEALTH CLAIM ON REDUCING THE RISK OF HEART
DISEASE
[Editor's Note: You would have to eat 6 bowls of Quaker Oats to get the same
anount of beta glucan as contained in a single tablet of our Beta Glucan]
FDA will display at the Federal Register a final rule allow- ing health claims
on the labels of foods containing soluble fiber from whole oats (rolled oats,
oat bran and oat flour) noting that these foods, as part of a diet low in
saturated fat and choles- terol, may reduce the risk of heart disease. The
following may be used to answer questions. FDA regulates health claims on food
labels under provisions of the Nutrition Labeling and Education Act of 1990 to
ensure that claims are accurate and not misleading to consumers. The law allows
the agency to authorize a health claim only if there is significant scientific
agreement that the claim is true. In allowing this health claim, FDA concluded
that the beta- glucan soluble fiber of whole oats is the primary component
responsible for the total and LDL blood cholesterol-lowering effects of diets
that contain these whole oat-containing foods at appropriate levels. This
conclusion is based on review of scientific evidence indicating a relationship
between the soluble fiber in these whole oat-containing foods and a reduction in
the risk of coronary heart disease. Food products eligible to bear the health
claim include oat bran and rolled oats, such as oatmeal, and whole oat flour.
Oat bran and rolled oats were the two food products named in a petition
submitted by The Quaker Oats Company in March 1995. FDA added whole oat flour to
this final rule in response to data provided in comments following the agency's
publication of the proposed rule on January 4, 1996. The data submitted showed
that whole oat flour is nutritionally equivalent to rolled oats and, more
importantly, has similar effects on serum lipids. In the final rule, FDA
acknowledges that sources of beta- glucan soluble fiber other than from whole
oats, and certain soluble fibers other than beta-glucan, are also likely to
affect blood lipid levels. However, FDA must await evidence on these other
sources before making a judgment on their effects. To qualify for the health
claim, the whole oat-containing food must provide at least 0.75 grams of soluble
fiber per serving. The amount of soluble fiber needed for an effect on
cholesterol levels is about 3 grams per day. Adding whole oat flour to the list
of substances eligible to be the subject of a claim means that many products
will qualify for the claim, thus making it possible that oat-containing products
could be consumed as many as 4 times a day. Examples of how the newly allowed
health claim may be used are: "Soluble fiber from foods such as oat bran,
as part of a diet low in saturated fat and cholesterol, may reduce the risk of
heart disease." or "Diets low in saturated fat and cholesterol that
include soluble fiber from oatmeal may reduce the risk of heart disease."
The words, "Diets low in saturated fat and cholesterol" must be
included in any such health claim because FDA concluded, after reviewing
comments, that consumers might otherwise be misled into thinking that eating a
diet high in oats is all that is necessary to reduce the risk of heart disease.
The final rule will be published later this week in Federal Register